Besides being a methodological bedrock for experiments aiming to elucidate the role of insulin signalling in the brain, the question is whether nasal insulin administration therefore represents an attractive alternative medical regimen to current therapies to treat obesity-associated diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.